Stage Ii Lung Cancer AJCC V8

AUG 11, 2026 · PHASE 3 TRIAL

Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer

ClinicalTrials.gov

This is a Phase 3 trial registration with no results posted; the study is active but not yet recruiting and outcome data are not available.

AUG 10, 2026 · PHASE 3 TRIAL

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

ClinicalTrials.gov

This is a Phase 3 RCT registration with no results posted; the trial is actively recruiting and designed to compare durvalumab against observation in early-stage NSCLC after surgery, but outcome data are not yet available.